We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Pixantrone (BBR 2778) in Patients With Refractory Acute Myelogenous Leukemia (AML)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00106600
Recruitment Status : Completed
First Posted : March 29, 2005
Last Update Posted : August 22, 2007
Information provided by:
CTI BioPharma

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Estimated Study Completion Date : March 2007